Neuronetics, Inc. stock is down -8.29% since 30 days ago. The next earnings date is Mar 5, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 16.67% of the previous 5 February’s closed higher than January.
Neuronetics, Inc. offers non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood.
Unlock Exclusive Market Insights! Receive timely updates on market developments. Sign up & stay informed!